Experts say GLP-1 drugs offer benefits beyond weight loss, but common mistakes like skipped labs and poor nutrition can ...

Wegovy, Ozempic and Mounjaro are weight loss and diabetes drugs that have made quite a splash in health news. They target ...

GLP-1 medications that suppress appetite are allowing people to better manage diabetes and obesity. As weight-loss drug ...

If you are trying to lose weight, you need to be careful about which supplements you chose since some supplements can cause ...

As many of us know, keeping weight in check can be hard. National data reflect that reality. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact on ...

Add Yahoo as a preferred source to see more of our stories on Google. Polling shows that 1 in 8 Americans have tried GLP-1 drugs. zimmytws/iStock via Getty Images Plus The Trump administration is ...

The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, including whether it could be linked to liver and heart problems, according to th ...

More than 40 percent of Americans are living with obesity—and it’s linked to serious health risks, including heart disease ...

Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...

Weight loss and diabetes drugs may reduce brain damage linked to Alzheimer’s, but human studies show mixed results.

Early results from a pilot study show the minimally invasive endoscopic intervention reduces the weight gain that occurs ...